CONGRESS WEALTH MANAGEMENT LLC / DE / – Neurocrine Biosciences, Inc. Transaction History
CONGRESS WEALTH MANAGEMENT LLC / DE / portfolio value:
$11.65M
portfolio value
CONGRESS WEALTH MANAGEMENT LLC / DE / quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.28% | 4.49K shares | 1.39M | $106.21 | 109.71K |
| Q2 2022 | share | Decrease | -0.39% | -416 shares | 353K | $97.48 | 105.21K |
| Q1 2022 | share | Increase | +82.65% | 47.79K shares | 4.97M | $93.75 | 105.63K |
| Q4 2021 | share | Increase | 0.00% | 57.83K shares | 4.92M | $84.63 | 57.83K |